Pharmaceutical manufacturer
Appears in 1 story · Last updated Oct 14, 2026
Recalling 22 lots of Argatroban Injection
Par Health pulled 22 lots of its Argatroban Injection off the market after finding bits of cellulose, plastic, and possible stainless steel in the anticoagulant. The injectable treats blood clots in patients with heparin-induced thrombocytopenia, a rare immune reaction to the common blood thinner.
Updated Oct 14
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
